Sanofi (SNY) Operating Margin (QoQ) (2009 - 2026)
Sanofi (SNY) Operating Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.03 Bn | 631.27 Bn | 17.26 Bn |
| 2 | AbbVie | 469.49 Bn | 462.92 Bn | 12.70 Bn |
| 3 | Merck | 375.14 Bn | 368.00 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.92 Bn | 295.23 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.73 Bn | 252.83 Bn | 12.86 Bn |
| 6 | Amgen | 236.80 Bn | 222.81 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.42 Bn | 179.24 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.16 Bn | 101.99 Bn | 8.24 Bn |
| 10 | Sanofi | 55.18 Bn | 47.80 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 466.00 |
| Mar 31, 2026 | 23,673.00 |
| Dec 31, 2025 | -23,705.00 |
| Sep 30, 2025 | -321.00 |
| Jun 30, 2025 | 72.00 |
| Mar 31, 2025 | -22,224.00 |
| Dec 31, 2024 | 23,116.00 |
| Sep 30, 2024 | -713.00 |
| Jun 30, 2024 | -104.00 |
| Mar 31, 2024 | 48.00 |
| Dec 31, 2023 | 800.00 |
| Sep 30, 2023 | -711.00 |
| Jun 30, 2023 | -35.00 |
| Mar 31, 2023 | -498.00 |
| Dec 31, 2022 | 1,227.00 |
| Sep 30, 2022 | -624.00 |
| Jun 30, 2022 | 176.00 |
| Mar 31, 2022 | 291.00 |
| Dec 31, 2021 | 291.00 |
| Sep 30, 2021 | -513.00 |